8-K: SRx Health Solutions Completes Merger with Better Choice Company, Announces Name Change and $8.8 Million Private Placement

SRx Health Solutions finalizes its merger with Better Choice Company, changes its name and ticker symbol, and secures $8.8 million through a private placement.

Summary

• SRx Health Solutions, Inc. (formerly Better Choice Company) has completed its business combination with SRx Health Solutions, Inc.
• The company also closed an $8.8 million private placement involving the sale of common stock and pre-funded warrants to an institutional investor at $2.18 per share.
• In connection with the merger, Better Choice issued 28.6 million shares of common stock.
• The company's legal name has changed to SRx Health Solutions Inc., and its ticker symbol on the NYSE American will change from BTTR to SRXH, effective April 30, 2025.
• Former Better Choice Company shareholders retain 16% ownership of the combined entity, while SRx Health's former stockholders hold approximately 84% of the total combined voting power.
• The merger is treated as a reverse merger for accounting purposes, with SRx Health being the acquirer.
• Following the closing date, the board of directors consists of five members: Adesh Vora, Simon Conway, David White, Michael Young and Lionel Conacher.
• Adesh Vora was appointed as Executive Chairman, and Davender Sohi was appointed as President of the Company.
• Kent Cunningham and Carolina Martinez were ratified and confirmed as maintaining the same respective positions with the Company.

Sentiment

Score: 7

Explanation: The announcement is generally positive, highlighting the completion of a merger and a successful capital raise. However, the company's historical losses and the risks associated with its business should be considered.

Positives

• The merger positions the combined company as a leading global health and wellness company.
• The $8.8 million private placement provides additional capital for the company.
• The company has a new Executive Chairman and President.
• For the year ended at September 30, 2023, SRx Health's revenue was approximately CAD$161 million and its Adjusted EBITDA was CAD$11.4 million and for the nine months ended at June 30, 2024, its revenue was $159 million and its Adjusted EBITDA was CAD$6.2 million.

Negatives

• Existing Better Choice Company shareholders now hold a minority stake (16%) in the combined entity.
• The company has historically reported net losses, and any losses in the future could cause the quoted price of the Company's common stock to decline or have a material adverse effect on the Company's financial condition, its ability to pay its debts as they become due, and on its cash flows.

Risks

• The company's ability to raise sufficient capital to finance its planned operations.
• Market acceptance of the company's technology and product offerings.
• The company's ability to attract and retain key personnel.
• The company's ability to protect its intellectual property.
• Estimates of the company's current cash position and future needs.
• There is a substantial doubt about the Company's ability to continue as a going concern.
• If we are unable to manage future expansion effectively, our business may be adversely impacted.

Future Outlook

The combined company aims to be a leading global health and wellness company, providing better products and solutions for pets, people, and families.

Management Comments

• Michael Young, Chairman of Better Choice Company, commented, 'We want to thank our existing shareholders, the NYSE, and our new shareholders at SRX. This is a transformative opportunity that positions Better Choice as a leading global health and wellness company. We look forward to sharing updates with our shareholders in the future.'

Industry Context

The merger reflects a trend of consolidation in the health and wellness sector, with companies seeking to expand their product offerings and market reach.

Comparison to Industry Standards

• It is difficult to compare the results to industry standards without more detailed financial information about SRx Health and Better Choice Company.
• Comparable companies in the specialty pharmacy space include McKesson Corporation and Loblaw.
• Halo competes with manufacturers of conventional pet food such as Mars, Nestl and Big Heart Pet Brands (part of the J.M. Smucker Company), and manufacturers of specialty and natural pet food such as Blue Buffalo (part of General Mills), Wellness, Fromm, Orijen, Merrick (part of Nestl), Stella and Chewy, Open Farm and Freshpet.

Management Changes

Stakeholder Impact

• Shareholders: Existing Better Choice shareholders experience dilution, while SRx Health shareholders gain control.
• Employees: Potential changes in organizational structure and job roles.
• Customers: Potential for expanded product offerings and improved services.
• Suppliers: Potential for changes in supply chain relationships.
• Creditors: Potential impact on debt obligations and financial stability.

Next Steps

• The company will operate as a combined entity.
• The company will change its ticker symbol to SRXH on April 30, 2025.
• The company will share updates with shareholders in the future.
• The Company intends to file the financial statements of SRx Health required by Item 9.01(a) as part of an amendment to this Current Report on Form 8-K not later than 71 calendar days after the date this Current Report on Form 8-K is required to be filed.
• The Company intends to file the pro forma financial information required by Item 9.01(b) as part of an amendment to this Current Report on Form 8-K not later than 71 calendar days after the date this Current Report on Form 8-K is required to be filed.

Key Dates

Keywords

merger, acquisition, SRx Health Solutions, Better Choice Company, private placement, health and wellness, pharmacy, pet health, financial results